GlassScriptPhysician profile
Nadine Nguyen
NPI 1104165802
$2,868.21
in general payments reported to CMS, 2019-2025
26 companies · $846 in 2025
The $846 reported for 2025 was more than what 82% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $194 · 2022: $1,137 · 2023: $205 · 2024: $486 · 2025: $846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,537.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,332.19 | 2021-2025 | Interstim |
| Endo USA, INC. | $224.97 | 2024-2025 | Xiaflex, Aveed |
| Teleflex LLC | $168.41 | 2024-2025 | Barrigel, Urolift |
| Neurocrine Biosciences, INC. | $124.99 | 2025 | |
| Astellas Pharma US INC | $99.95 | 2021 | |
| Abiomed | $95.55 | 2025 | |
| Sumitomo Pharma America, INC. | $94.99 | 2024-2025 | Gemtesa, Orgovyx |
| Axonics, INC. | $94.60 | 2022-2023 | Axonics |
| Abc Home Medical Supply, INC. | $90.87 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $70.61 | 2025 | |
| Endo Pharmaceuticals INC. | $59.84 | 2021-2023 | Aveed, Edex, Xiaflex |
| Urovant Sciences INC | $52.82 | 2021-2022 | |
| Pfizer INC. | $36.28 | 2025 | |
| Dendreon Pharmaceuticals LLC | $33.70 | 2024 | Provenge |
| Procept Biorobotics Corporation | $32.27 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $30.92 | 2025 | |
| Photocure INC | $29.50 | 2022-2024 | Cysview |
| Bayer Healthcare Pharmaceuticals INC. | $27.41 | 2025 | |
| Convatec INC. | $26.29 | 2022-2023 | |
| 180 Medical, INC. | $25.82 | 2024 | |
| Coloplast Corp | $24.99 | 2024 | |
| Gilead Sciences, INC. | $23.33 | 2025 | |
| Blue Earth Diagnostics | $19.91 | 2021 | |
| Boston Scientific Corporation | $16.76 | 2025 | Ams 700 |
| Janssen Biotech, INC. | $15.63 | 2025 | |
| Olympus America INC. | $15.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadine Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.